First Time Loading...

Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 781 000 KRW
Updated: May 15, 2024

Samsung Biologics Co Ltd
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Samsung Biologics Co Ltd
Selling, General & Administrative Peer Comparison

Comparables:
P
087010
K
278650
S
237690
F
220100
L
141080

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Samsung Biologics Co Ltd
KRX:207940
Selling, General & Administrative
-₩575.5B
CAGR 3-Years
-74%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
P
Peptron Inc
KOSDAQ:087010
Selling, General & Administrative
-₩5.3B
CAGR 3-Years
-7%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
K
Knotus Co Ltd
KOSDAQ:278650
Selling, General & Administrative
-₩33.4B
CAGR 3-Years
-2%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
S
ST Pharm Co Ltd
KOSDAQ:237690
Selling, General & Administrative
-₩44.7B
CAGR 3-Years
-25%
CAGR 5-Years
-36%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Selling, General & Administrative
-₩6.8B
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Selling, General & Administrative
-₩17.2B
CAGR 3-Years
-22%
CAGR 5-Years
-29%
CAGR 10-Years
-28%

See Also

What is Samsung Biologics Co Ltd's Selling, General & Administrative?
Selling, General & Administrative
-575.5B KRW

Based on the financial report for Dec 31, 2023, Samsung Biologics Co Ltd's Selling, General & Administrative amounts to -575.5B KRW.

What is Samsung Biologics Co Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-50%

Over the last year, the Selling, General & Administrative growth was -38%. The average annual Selling, General & Administrative growth rates for Samsung Biologics Co Ltd have been -74% over the past three years , -50% over the past five years .